XML 32 R21.htm IDEA: XBRL DOCUMENT v3.23.2
GENERAL (Details) - USD ($)
$ in Thousands
1 Months Ended 6 Months Ended
Aug. 05, 2013
Mar. 30, 2018
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Nov. 10, 2021
GENERAL [Abstract]            
Upfront payment received $ 10,000 $ 10,000        
Accrued milestone payment   15,500        
Potential milestone compensation   $ 200,000        
Preclinical milestone compensation $ 23,000          
Amount of investment in Compugen     $ 12,000     $ 20,000
Accumulated deficit     474,388   $ 455,773  
Net loss     18,615 $ 18,854    
Net cash used in operating activities     $ 18,617 $ 20,683